Clinical Trial Update: Baricitinib Curative Repression of HIV-1 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating baricitinib for potential HIV-1 suppression. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Baricitinib (baricitinib)

Snippet

Sponsor: Emory University | Conditions: HIV Infection, HIV | Phase 2 | Status: NOT_YET_RECRUITING